
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Loyalty Program from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/loyalty-program/topic/15438/</link>
        <description>Articles tagged with Loyalty Program from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Pfizer&apos;s Lipitor share slips, casting doubt on power of a loyalty program to save the brand</title>
          <description>Seven weeks after Pfizer&apos;s main Lipitor patent expired in the US, the drug is down to 32% market share and at least one name-brand analyst is casting doubt on the brand&apos;s survival strategy.</description>
          <link>http://www.mmm-online.com/pfizers-lipitor-share-slips-casting-doubt-on-power-of-a-loyalty-program-to-save-the-brand/article/224726/</link>
          <pubDate>Wed, 25 Jan 2012 19:38:51 GMT</pubDate>
          <itunes:summary>Seven weeks after Pfizer&apos;s main Lipitor patent expired in the US, the drug is down to 32% market share and at least one name-brand analyst is casting doubt on the brand&apos;s survival strategy.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  